ASST heads into the weekend with a damaging juxtaposition: a $2.55 billion shelf prospectus filed on June 5 landing the same week the stock fell 21%.
The prospectus is the headline story this week. Strive registered up to $2.55 billion in Class A common stock for potential issuance — a filing that frames the company's ambitions in bitcoin-treasury scale but sent immediate dilution anxiety through the register. The stock dropped 7.3% on June 5 alone and is now at $13.92, down 15.7% over the past month. With 22.3% of the free float already sold short, the announcement landed into an already sceptical tape.
The borrow market reflects just how crowded the short book has become. Availability has been at 0% for weeks — every share in the lending pool is already out on loan, matching the 52-week tightest reading. Yet paradoxically, the borrow cost has been easing rather than tightening: the cost to borrow has fallen roughly 27% over the past month to 1.59% annually, well off the 2.79% level seen in late April. That compression suggests short sellers are not fighting one another for new inventory — the position is already built, and no fresh wave of shorting is pressing the borrow rate higher. Options add a nuanced wrinkle. The put/call ratio jumped to 0.116 on June 5, more than three and a half standard deviations above its 20-day average of 0.075 — an abrupt spike in hedging demand that tracks almost exactly with the prospectus filing, even though the ratio remains low in absolute terms.
The Street, to a notable degree, is not budging. All four covering analysts rate ASST a buy, and the mean price target of $29.60 implies more than a double from current levels. Benchmark initiated coverage just this week with a buy and a $32 target. TD Cowen and HC Wainwright lifted targets earlier in May. The bull case rests on Strive's BTC holdings, the management team anchored by Vivek Ramaswamy, and the thesis that bitcoin adoption provides a structural tailwind. Bears focus on the exact mechanism that drove this week's move: heavy bitcoin dependence means quarterly results swing wildly with BTC price, and equity issuance — Strive's primary funding lever — is dilutive by definition. The company missed Q1 EPS estimates badly in May, reporting $(5.19) against a $(2.56) consensus, while revenue of $2.76 million also fell short. Valuation remains deeply negative on earnings-based measures, reflecting a pre-profitability structure.
Institutional ownership tells its own story. FMR (Fidelity) holds 9.8% after adding more than 6.3 million shares, and BlackRock built a nearly 5% stake through April. Ramaswamy himself trimmed roughly 1.4 million shares through late May, reducing his holding to 7.8% — a modest reduction but notable given his role as a founder figure. The ORTEX short score of 71 has been remarkably stable over the past two weeks, hovering in a tight band, suggesting the overall positioning dynamic is consolidating rather than escalating despite the price pressure.
What to watch next is straightforward: whether the shelf filing translates into an actual equity raise, the size of any deal, and how BTC price moves interact with the stock in the days following — given that the two have become effectively co-dependent in the minds of investors on both sides of this trade.
See the live data behind this article on ORTEX.
Open ASST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
